ROIV — Roivant Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapMomentum Trap

Annual balance sheet for Roivant Sciences, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,060	1,677	6,536	4,887	4,292
Net Total Accounts Receivable
Net Total Receivables	—	32.7	82.8	—	770
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,147	1,799	6,732	5,000	5,167
Net Property, Plant And Equipment	86.9	92.3	66	101	92.4
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,585	2,390	7,222	5,437	5,709
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	184	272	267	149	281
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	928	1,232	1,254	749	1,181
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,657	1,158	5,969	4,688	4,527
Total Liabilities & Shareholders' Equity	2,585	2,390	7,222	5,437	5,709
Total Common Shares Outstanding